For Fresenius Medical Care, 2010 was
as successful as it was eventful.
We forged new partnerships for the
benefit of our patients, further advanced
our business with products and
services, and set the course for our
U.S.Dr. Ben Lipps presented with awards
Dr. Ben J. Lipps, Chief Executive Officer of Fresenius Medical Care, is honored twice in 2010 for his business achievements. The University Kidney Research Organization (UKRO), a non-profit organization that supports medical research into the prevention and treatment of kidney diseases, presents Dr. Lipps with an award for his “outstanding achievement in business and industry for the benefit of kidney patients”. Dr. Lipps is also named “Strategist of the Year” for the second consecutive year; the strategy consulting firm Bain & Company, the WHU Otto Beisheim School of Management and Financial Times Germany award this title to chief executives who provide their companies with a clear strategic direction, enabling them to achieve above-average increases in revenue, employment, profitability and capital market performance.
U.S.A new generation of equipment for new requirements
In November, just in time for the most important industry conference, ASN Renal Week, and for the introduction of the new reimbursement system for dialysis in the U.S., Fresenius Medical Care launches the 2008T, its latest series of hemodialysis machines for the North American market. The 2008T is the first therapy system approved in the U.S. that is equipped with both modern dialysis technology and innovative software for clinical treatment data. This means that doctors and clinic staff can quickly and easily capture the data needed to measure the quality of treatment, directly at the patient’s chairside. The purpose of the machine is not only to simplify day-to-day processes in the clinic and further improve clinical data and quality management, but also to support doctors and clinic operators in the U.S. in meeting requirements for documenting treatment outcomes as part of the new bundled reimbursement system.
GREAT BRITAINCapital market meets dialysis company
In September, Fresenius Medical Care invites analysts and investors to attend its “Capital Markets Day” near London. Board members and managers provide an insight into current business performance, present new products and processes and explain the current situation on the global markets as well as the goals for the coming financial years. The financial market experts are particularly interested in how the Company assesses the introduction of the new bundled reimbursement system in the U.S. The conference is streamed live on the internet. The aim of the Capital Markets Day is to provide analysts as well as institutional investors with as comprehensive and transparent a picture of Fresenius Medical Care as possible. This year’s event also includes the opportunity to view the latest generation of dialysis machines.
ARGENTINALearning for life in the dialysis clinic
Fresenius Medical Care Argentina congratulates its patients on gaining their school-leaving diploma. The proud graduates were the first participants in a project launched by the Company together with the Ministry of Education for the Province of Buenos Aires: At four Fresenius Medical Care dialysis centers, around 80 adult patients are being taught by state teachers during their treatment, giving them the chance to gain their primary school diploma, which, in Argentina, is obtained after seven years of schooling. Around 35% of Fresenius Medical Care’s patients in Argentina do not have a school-leaving qualification. Their low level of education makes it difficult for them to find employment in an already tight labor market, and adds to the difficulties typically faced by people undergoing dialysis, especially the disciplined adherence to their treatment plan and the regular taking of medication.
U.S.Award for a quarter of a century on dialysis
In November, Fresenius Medical Care signs a new partnership with the American Association of Kidney Patients (AAKP), an organization that has worked to improve the quality of life of kidney patients for over 40 years. Together with the AAKP, Fresenius Medical Care will in future present a special award to patients who have been on dialysis treatment for 25 years or longer. The recipients of the award will be honored for their courage in spite of their illness, their healthy lifestyle and their discipline in adhering to their treatment plan, all of which make them role models for other patients.
U.S.Recognition for crisis management
The International Association of Emergency Managers (IAEM) commends Fresenius Medical Care North America for its integrated crisis management program. Emergency experts from the IAEM praise the professional manner in which the Company responded to crises such as the severe earthquake in Haiti, the H1N1 pandemic and, previously, hurricanes on the U.S. coast, as setting an example for the entire industry.
ASIA-PACIFICClinic network expanded
In May, Fresenius Medical Care takes over the second-largest dialysis provider in Asia-Pacific, Asia Renal Care, thus strengthening its position as market leader in dialysis services in the region. Around 5,300 patients are treated in some 80 Asia Renal Care clinics. In Asia-Pacific, about 750,000 patients are reliant upon life-sustaining dialysis treatment. For the coming years, Fresenius Medical Care expects strong market growth in the region. The number of dialysis patients there is forecast to exceed one million within the next five years.
SWITZERLANDNew joint company for pharmaceuticals
In December, Fresenius Medical Care and the Swiss Galenica Group found a joint company: Vifor Fresenius Medical Care Renal Pharma Ltd., as it is called, is to develop and distribute innovative drugs for kidney patients. These include medications to treat anemia and regulate the bone metabolism in both dialysis patients and people in earlier stages of chronic kidney disease who do not yet need dialysis treatment. Fresenius Medical Care will hold a 45% share in the new company.
HAITI AND CHILEAid for earthquake victims
2010 is overshadowed by two devastating earthquakes in Chile and Haiti. In both countries, Fresenius Medical Care provides rapid assistance in treating dialysis patients: In January, the Company donates around twelve tons of dialysis material to Doctors Without Borders and other organizations on the Caribbean island of Haiti. At the end of February, within 48 hours of the disaster in Chile, the employees of Fresenius Medical Care’s crisis management team are able to put almost all of the Company’s own clinics back into service, and arrange treatment for patients of the one clinic which is no longer operable. In close cooperation with the Chilean Ministry of Health, the Company also creates capacity to treat up to 400 additional patients from areas affected by the earthquake.
AUSTRIANew research department in Krems
In September, Fresenius Medical Care opens a new department for research and development in sorbent technologies in the Austrian town of Krems. Since 2003, Fresenius Medical Care has produced products for various sorbent therapies in Krems – for example, to be used in the Prometheus system for the detoxification of patients with liver failure or in procedures that remove antibodies from the bloodstream in serious autoimmune diseases. With this new department, Fresenius Medical Care has further intensified its relations with the Danube University Krems. The Company has been supporting the university’s research on extracorporeal bloodpurifying procedures (i.e. ones that take place outside the body) with sorbents for almost 20 years. The long-standing partnership with the specialist team at the university was also one of the reasons for the decision to invest further in Krems.
AUSTRALIADialysis with solar power
In Australia, Fresenius Medical Care provides support for a solar-powered dialysis unit – the first in the world to the best of our knowledge. A business partner, the head of nephrology at an Australian health care provider, builds the solar unit on the roof of his dialysis center with funding from Fresenius Medical Care. Even during the relatively dark winter months of 2010, the unit is able to cover more than 90% of the energy required for dialysis equipment and water treatment. On average over the year, the dialysis unit even generates more electricity than it consumes in these two areas. The energy gained is fed into the local electricity grid and offset against overall electricity costs. The joint project has met with interest from professional circles, for example, at ASN Renal Week, the leading industry conference in the U.S.
RUSSIAGerman Federal President Wulff visits Fresenius Medical Care
In October, on his first major trip abroad after being elected German Federal President, Christian Wulff visits a Fresenius Medical Care dialysis center in the Russian city of Ulyanovsk, 700 kilometers east of Moscow. Accompanied by a 50-strong delegation of business representatives, politicians and journalists, he takes the time to tour the facility and learn about the possibilities of dialysis. In discussions with doctors, nurses and patients, he seems impressed by both the high standard of treatment and technological innovation. The clinic in Ulyanovsk with over 300 patients is one of ten dialysis centers that Fresenius Medical Care now operates in Russia.